Form 4: Orthopediatrics Corp. Executive Gregory A. Odle Reports Stock Transactions
SEC Form 4 Filing
Gregory A. Odle, President of Scoliosis at Orthopediatrics Corp., reports acquisition and disposal of company stock on March 15 and 18, 2025.
Summary
- Gregory A. Odle, President of Scoliosis at Orthopediatrics Corp., filed a Form 4 detailing changes in beneficial ownership.
- On March 15, 2025, Odle acquired 38,773 shares of common stock at $0.
- On March 18, 2025, Odle disposed of 5,359 shares of common stock at a price of $24.86 per share.
- Following these transactions, Odle beneficially owns 148,788 shares of Orthopediatrics Corp. common stock, including 93,291 restricted stock awards.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock transactions by an executive.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in the healthcare industry.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| 03/15/2025 | Acquisition of 38,773 shares of common stock. |
| 03/18/2025 | Sale of 5,359 shares of common stock at $24.86 per share. |
| 03/18/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.